Exome sequencing shows same pattern of clonal tumor mutational burden, intratumor heterogenicity and clonal neoantigen between autologous tumor and Vigil product

Abstract Retrospective data support overall survival (OS) advantage to high clonal tumor mutation burden (cTMB), high clonal neoantigen load (cNEO) and low intratumor heterogeneity (ITH) in cancer patients who receive immunotherapy. In order to explore this relationship prospectively with Vigil, a t...

Full description

Bibliographic Details

Published in:	Scientific Reports
Main Authors:	David Willoughby, Ernest Bognar, Laura Stanbery, Casey Nagel, Gladice Wallraven, Aman Pruthi, Nicholas Bild, Ericca Stamper, Donald Rao, Adam Walter, John Nemunaitis
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-03-01
Subjects:	Clonal tumor mutation burden Intratumor heterogeneity Autologous tumor Tumor mutation burden Neoantigen Vigil
Online Access:	https://doi.org/10.1038/s41598-025-90136-7